Primaquine for Radical Cure of Plasmodium vivax and Plasmodium ovale Malaria: An Observational Survey (2008–2010)

Authors


Corresponding Author: Jean-François Faucher, MD, PhD, Infectious and Tropical Diseases Department, Besançon University Hospital, Besançon, France. E-mail: jffaucher@chu-besancon.fr

Abstract

Since 2008, the French guidelines have promoted the systematic use of 30 mg/day of primaquine for the radical cure of Plasmodium vivax and Plamodium ovale infections. We observed three relapses in 10 patients with P vivax acquired in French Guiana. No relapses were seen in West African P ovale patients.

Ancillary